Phosphatase Subfamily PPM1D

From PhosphataseWiki
Revision as of 09:42, 24 July 2017 by Gerard (Talk | contribs)

Jump to: navigation, search

Phosphatase Classification: Fold PPM (PP2C): Superfamily PPM (PP2C): Family PPM (PP2C): Subfamily PPM1D (WIP1)

Evolution

The PPM1D (WIP1) subfamily most likely emerged in holozoa. It is single copy in most genomes, including human genome. See internal gOrtholog database.

Domain

PPM1D has a single domain, the phosphatase domain of PPM (PP2C) fold.

Function

Cancer

Consistent with its moleuclar function (see below), human PPM1D is implicated in different cancer types [1]:

  • PPM1D promotes progression and invasion of aggressive medulloblastoma variants, crosstalking with CXCR5 and GRK5 [2].
  • PPM1D is highly expressed in non-small-cell lung cancer (NSCLC)[3]. Truncating mutations at exon 6 of PPM1D were found in blood DNA of NSCLC, which suggests that it could be used as a biomarker for NSCLC [4].
  • PPM1D regulates the proliferation and invasiveness of nasopharyngeal carcinoma (NPC) cells in vitro [5].
  • PPM1D is a frequent target of somatic mutation in brainstem gliomas [6].

Several inhibitors target PPM1D to suppress cancer (e.g. [7]).

Cell cell checkpoint and DNA damage response

Human PPM1D is also known as Wild-type p53-induced phosphatase 1 (WIP1). It functions as a negative regulator of several tumor suppressor genes and as a modulator of the epigenetic state of the genome [8]. It plays a key role in the DNA damage response (DDR), by dephosphorylating multiple proteins in the DDR and cell cycle checkpoint pathways, including Atm, p53, Chk1, Chk2, Mdm2, Mdm4 and p38 MAPK. Several substrate proteins are directly involved in sensing and repairing DNA damage, suchas Atm, p53, Chk2, XPA, XPC and UNG2 [1].

Other functions

PPM1D is highly expressed in haematopoietic stem cells (HSC)s but decreases with age, and WIP1-deficient (Wip1-/-) mice exhibited multifaceted HSC aging phenotypes, including the increased pool size and impaired repopulating activity [9].

PPM1D (WIP1) controls antigen-independent B cell development in a p53-dependent manner [10].

PPM1D negatively regulates neutrophil migration and inflammation, probably through more than one signaling pathways, such as p38 MAPK and NF-κB [11].

Human PPM1D (WIP1) positively modulates the Hedgehog pathway by enhancing transcription factor GLI1 function, in a manner dependent on its phosphatase activity, but no direct evidence has shown PPM1D dephosphorylates GLI1 [12].

References

Error fetching PMID 24632620:
Error fetching PMID 25879755:
Error fetching PMID 25381821:
Error fetching PMID 24135283:
Error fetching PMID 24272082:
Error fetching PMID 26358280:
Error fetching PMID 23146903:
Error fetching PMID 24395919:
Error fetching PMID 26012568:
Error fetching PMID 25742468:
Error fetching PMID 24880341:
Error fetching PMID 24801909:
  1. Error fetching PMID 25381821: [Emelyanov14]
  2. Error fetching PMID 24632620: [Buss15]
  3. Error fetching PMID 24272082: [Fu14]
  4. Error fetching PMID 25742468: [Zajkowicz15]
  5. Error fetching PMID 24801909: [Zhang14b]
  6. Error fetching PMID 24880341: [Zhang14a]
  7. Error fetching PMID 26358280: [Ogasawara15]
  8. Error fetching PMID 24135283: [Filipponi13]
  9. Error fetching PMID 25879755: [Chen15]
  10. Error fetching PMID 26012568: [Yi15]
  11. Error fetching PMID 24395919: [Sun14]
  12. Error fetching PMID 23146903: [Pandolfi13]
All Medline abstracts: PubMed | HubMed